"Designing Growth Strategies is in our DNA"
The global pulmonary function testing system market size was valued at USD 136.6 million in 2021. The market is projected to grow from USD 141.8 million in 2022 to USD 190.2 million by 2029, exhibiting a CAGR of 4.3% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with pulmonary function testing systems experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. Based on our analysis, the pulmonary function testing system market exhibited a slower growth of 1.4% in 2020 as compared to 2019.
Pulmonary function testing system is a device that performs various pulmonary function tests such as respiratory mechanics, nitrogen washout, spirometry, lung volumes, vital capacity, plethysmography, and diffusion capacity. There are two types of devices available namely complete, and portable systems. These devices can be utilized to monitor people suffering from severe breathing complaints such as asthma and COPD.
The pulmonary function testing system market growth is attributed to the growing occurrence of chronic respiratory ailments. Furthermore, technological progressions, such as portable systems are anticipated to increase the demand for these devices in the coming years. Additionally, rising awareness regarding the usage of these devices and increasing product launches by the companies are predicted to increase the market growth during the forecast timeframe.
COVID-19 Pandemic Slowed Market Growth in 2020 due to Shutdown of Pulmonary Clinics
The influence of COVID-19 resulted in lesser demand for pulmonary function testing systems during the market analysis period. This is attributed to the substantial decrease in the implementation of systems for testing pulmonary function during the peak time of COVID-19. However, after the relaxation of lockdown in some countries, the PFT resumed in healthcare facilities with the RT-PCR test. The global market witnessed a slow growth rate of 1.4% in 2020 as compared to 3.3% in 2019.
The widespread disruption caused by COVID-19 has significantly affected the manufacturing of these systems. The imposition of lockdown in potentially affected areas has led to a halt in the supply chain of portable systems leading to a decrease in sales. However, at the end of 2020, testing centers and clinics were resumed, contributing to the market's substantial growth in 2021.
Furthermore, multiple organizations, such as the Canadian Thoracic Society, European Thoracic Society, and the American Thoracic Society, issued guidelines to be followed amid the COVID-19 outbreak while resuming services. This increased the number of patients testing pulmonary function and also increased the demand for these systems from various healthcare facilities.
Request a Free sample to learn more about this report.
Shift towards Portable Systems from Complete Systems to Thrive Market Growth
The companies functioning in the global market incessantly emphasize on developments, such as launching portable systems with more parameters and promoting the adoption of these devices in independent clinics. These strategies shifted the adoption of complete to portable systems, thereby spurring the overall market growth.
Aspects such as immobile, low cost, and presence of standard parameters, such as lung volumes, diffusion capacity, and spirometry, stimulated the healthcare facilities to shift towards portable systems. Moreover, many market players are developing new portable systems to diagnose various chronic respiratory disorders, which is anticipated to drive market growth during the forecast period.
Increasing Prevalence of Respiratory Diseases to Drive Market
In recent years, respiratory ailments, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, lung cancer, and occupational lung diseases, have been the leading reasons of fatality across the globe. Furthermore, there is a considerable increase in the incidence of chronic obstructive pulmonary diseases and asthma globally, especially in developing countries.
In COPD and other chronic respiratory diseases, lung capacity is an important parameter. Lung capacity refers to the air volume in lungs at different respiratory cycle phases. The pulmonary function testing systems help to measure different parameters of the lungs with the help of various tests such as spirometry and plethysmography and diagnose COPD and other lung-related disorders.
Such a huge occurrence of chronic respiratory diseases necessitating pulmonary function tests and the rising focus of companies to increase their presence in developing countries for these systems are expected to boost the market growth in the coming years
Rising Awareness of Early Diagnosis and Advancements of Testing Systems to Propel the Market
Pulmonary function tests are non-invasive tests that analyze the functioning of the lungs. The tests measure capacity, lung volume, gas exchange, and flow rates and determine the treatment for certain lung disorders.
PFTs are very useful in identifying the early-stage abnormalities in asymptomatic patients and in evaluating the damage to the lungs before any signs and symptoms develop. Due to these reasons, pulmonary function testing has become important among physicians for screening and detection of pulmonary disorders.
Furthermore, the increasing diagnosis of lung function from pulmonary function tests have stimulated companies to introduce advanced testing systems in the market. The advanced product’s clearance by the U.S. FDA in the market is expected to increase its adoption among healthcare providers, especially in independent physician clinics.
The advancement of newly launched testing devices coupled with increasing awareness of devices among healthcare providers is expected to propel the market in the long run.
Risk of Cross Contamination and Lack of Skilled Healthcare Professionals in Underdeveloped Countries Hamper Market Growth
Pulmonary function testing represents a potential avenue for the transmission of infection due to the congregation of patients with lung disease and the potential for coughing and droplet formation surrounding pulmonary function test procedures.
These systems include mouthpieces, rebreathing valves, and tubings used in the laboratory. Mouthpieces are the most common cause of cross-infection during testing.
Factors, such as exposed surface areas, quality of upholstery, general clutter, air conditioning, optimum temperature, and humidity conditions, lead to the cross-infection such as the risk of the development of tuberculosis.
Furthermore, the complexity of these systems, which measures various parameters in diagnosing lung volume capacity requires skilled physicians and technicians. However, there is a shortage of trained healthcare professionals in developing countries.
Such unavailability of a skilled workforce to operate PFT systems and the high risk of contamination associated with these systems are expected to hamper the market growth during the forecast period.
To know how our report can help streamline your business, Speak to Analyst
Complete PFT Systems Segment to Hold a Prime Share due to the Growing Adoption in Hospitals
Based on type, the market is segmented into portable PFT systems and complete PFT systems
In 2021, the complete PFT systems segment held the highest pulmonary function testing system market share and was predicted to extend at a significant CAGR during the forecast period, 2022-2029. An increase in the number of hospitals requiring complete systems is expected to drive segmental growth. Moreover, the surging number of patient visits coupled with the huge occurrence of respiratory illness, such as asthma and COPD, are expected to increase the demand for complete systems.
The portable PFT systems segment is projected to expand at the highest CAGR during the forecast timeframe. The high growth rate of this segment is due to the increase in the adoption of portable systems in independent and diagnostics clinics. Moreover, factors such as increasing launches of these products for the diagnosis of asthma and COPD and rising air pollution are expected to surge its demand in the future.
Hospitals Segment to Continue Dominance Due to Rising Patient Visits
Based on end-user, the market is segmented into hospitals, physical examination (diagnostic) centers, physician groups (clinics), and others.
The hospitals segment held the largest market share and is expected to expand at a moderate CAGR during the forecast period. The segmental growth is due to the surging footfalls of asthma and COPD patients in the hospitals. Moreover, the growing adoption of complete systems for diagnosing patients in hospitals is expected to drive the segment's growth in the coming years.
The physician groups (clinics) segment is projected to expand at the highest CAGR during the forecast timeframe. The segmental growth is attributed to factors such as the growing incidence of chronic respiratory diseases, rising focus of key players in the market on introducing portable systems for clinics, and an increase in the implementation of these systems in clinics.
Such introduction of these systems in the physician groups (clinics) pooled with the increasing number of COPD and asthma patients in clinics is expected to boost the segmental growth during the forecast period.
North America Pulmonary function testing system market Size, 2021 (USD Million)
To get more information on the regional analysis of this market, Request a Free sample
The North America market was valued at USD 57.0 million in 2021 and is projected to expand at a substantial CAGR during the forecast period. The growth is due to the prompt implementation of portable systems and the bolstering usage of these devices in physician groups (clinics) in the region. Furthermore, an increasing prevalence of chronic respiratory diseases and rising hospital admissions are anticipated to propel the market growth across the region.
Europe is projected to expand at a reasonable CAGR during the forecast timeframe. The growth is due to the surging number of patients suffering from COPD and asthma and the growing number of visits to independent physician clinics to diagnose these diseases. Furthermore, the improvement in healthcare infrastructure and the presence of major players in this region surge the demand for PFT systems in the region.
The market in Asia Pacific is projected to grow at the largest CAGR during the forecast period. The market growth across the region is accredited to the growing awareness regarding the usage of pulmonary function tests and increasing emphasis on enhancing hospital infrastructure. Furthermore, the rising footprints of market players in developing countries of Asia Pacific are expected to propel the market during the forecast period.
The market in Latin America and the Middle East & Africa is anticipated to expand at a lower CAGR compared to other regions during the forecast period. The growth is attributed to the rising investments in healthcare improvement, increasing prevalence of COPD and asthma, and growing demand for diagnosing lung function across these regions.
Strong Product Portfolio of Companies to Strengthen their Market Position
The market is consolidated due to large market shares accounted for by key companies operating in the market.
VYAIRE MEDICAL, INC. and MGC Diagnostics Corporation accounted for the highest market share of the market. The large shares of these companies are due to their strong product portfolio of PFT systems and increasing focus on the approvals to introduce advanced devices in the market.
Moreover, the consistent focus of the key companies on introducing these systems in developing countries is expected to strengthen their market shares during the forecast period. Furthermore, companies, such as PulmOne Advanced Medical Devices, have been aggressively focusing on expanding their products and geographical presence worldwide.
Other companies with new product launches include ndd Medizintechnik AG, KoKo PFT, CHEST M.I., Inc., and other small & medium-sized market players. Moreover, a growing focus of companies on collaboration with healthcare providers is expected to fuel the global market growth in the coming years.
An Infographic Representation of Pulmonary Function Testing Systems Market
To get information on various segments, share your queries with us
The market research report provides a detailed competitive landscape and market dynamics. It focuses on key aspects, such as regulatory policies regarding the prevalence of major pulmonary diseases, such as COPD and asthma. Furthermore, the report provides information related to key industry developments such as mergers and acquisitions. In addition, the report includes insights related to industry trends and the impact of COVID-19 on the market.
Value (USD million)
Fortune Business Insights says that the global market stood at USD 136.6 million in 2021 and is projected to reach USD 190.2 million by the end of 2029.
The market is expected to expand at a CAGR of 4.3% during the forecast timeframe (2022-2029).
The complete PFT systems segment is set to lead the market by type.
The rising prevalence of chronic respiratory disorders, growing geriatric population, and rising awareness regarding PFT systems for the diagnosis of lung functioning are the key factors driving the market growth.
VYAIRE MEDICAL, INC. and MGC Diagnostics Corporation are the top players in the market.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry